Literature DB >> 16941013

Solid pseudopapillary neoplasms of the pancreas are associated with FLI-1 expression, but not with EWS/FLI-1 translocation.

Katharina Tiemann1, Markus Kosmahl, Julia Ohlendorf, Matthias Krams, Günter Klöppel.   

Abstract

Solid pseudopapillary neoplasms of the pancreas are rare pancreatic tumors with mostly benign behavior, affecting almost exclusively women. Their histogenetic origin is still unsolved, but a recently reported EWS/FLI-1 translocation t(11;22)(q24;q21) and the consistent expression of CD56 and the progesterone receptor, both genes located on the long arm of chromosome 11, point to chromosome 11q as a potential locus of gene aberration in solid pseudopapillary neoplasms. To further elucidate this issue, we studied 30 cases of solid pseudopapillary neoplasms by comparative genomic hybridization (CGH), fluorescent in situ hybridization (FISH) and immunohistochemistry. Immunohistochemically, 38% showed nuclear expression of FLI-1 and all cases revealed positivity for CD56 and the progesterone receptor, whereas no solid pseudopapillary neoplasm expressed CD34. No translocation of the EWS gene was found by FISH and no gross chromosomal gain or loss was detected by CGH. It is concluded that FLI-1 expression in solid pseudopapillary neoplasms is not associated with an EWS/FLI-1 translocation. In addition, there are no chromosomal gains or losses, especially on chromosome 11, where the FLI-1 gene is located adjacent to the gene for CD56 (NCAM). These data add another feature to the complex phenotypic appearance of solid pseudopapillary neoplasms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16941013     DOI: 10.1038/modpathol.3800664

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  6 in total

1.  Solid pseudopapillary neoplasm of the pancreas.

Authors:  Donna Cummins; Margaret Sheehan; John Bruzzi; Oliver McAnena
Journal:  BMJ Case Rep       Date:  2012-10-26

2.  Immunohistochemical features of the gastrointestinal tract tumors.

Authors:  Hannah H Wong; Peiguo Chu
Journal:  J Gastrointest Oncol       Date:  2012-09

3.  BCL9L expression in pancreatic neoplasia with a focus on SPN: a possible explanation for the enigma of the benign neoplasia.

Authors:  Cora Hallas; Julia Phillipp; Lukas Domanowsky; Bettina Kah; Katharina Tiemann
Journal:  BMC Cancer       Date:  2016-08-18       Impact factor: 4.430

4.  Clinicopathological factors associated with recurrence in patients undergoing resection of pancreatic solid pseudopapillary neoplasm.

Authors:  Oscar Paredes; Kori Paredes; Yoshikuni Kawaguchi; Carlos Luque-Vasquez; Iván Chavez; Juan Celis; Eduardo Payet; Eloy Ruiz; Francisco Berrospi
Journal:  Discov Oncol       Date:  2021-11-22

5.  LEF1, TFE3, and AR are putative diagnostic markers of solid pseudopapillary neoplasms.

Authors:  Eun Kyung Kim; Mi Jang; Minhee Park; Hoguen Kim
Journal:  Oncotarget       Date:  2017-10-16

Review 6.  Clinical update on the management of pseudopapillary tumor of pancreas.

Authors:  Gandhi Lanke; Faisal S Ali; Jeffrey H Lee
Journal:  World J Gastrointest Endosc       Date:  2018-09-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.